Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Gb Sciences Inc (OP: GBLX )

0.0070 +0.0007 (+11.11%)
Streaming Delayed Price Updated: 12:31 PM EDT, Aug 27, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Gb Sciences Inc

Cannabis Terpenes Reduce Inflammation, Says Gb Sciences Study
Gb Sciences, Inc. (OTCQB: GBLX), a leading plant-inspired, biopharmaceutical research and drug development company, co-published a study that demonstrates the potential of selected cannabinoids and... 
Via Benzinga
New Study Shows Promising Results In Treatment Of Parkinson's Disease With Cannabinoids
Biopharmaceutical research and drug development company, Gb Sciences, Inc. (OTCQB: GBLX), co-published a study in the journal Frontiers in Pharmacology that demonstrates the efficacy of its proprietary... 
Via Benzinga
Gb Sciences To Begin Dosage Study For Cannabinoid-Containing Drug For Treatment Of Parkinson's Disease
Gb Sciences, Inc. (OTCQB: GBLX) has selected the University of Lethbridge in Canada to complete a dose range study of Gb Sciences' patent-protected formulations in a rodent model of Parkinson's... 
Via Benzinga
Marijuana And Chronic Pain: Gb Sciences' Nanoparticle Technology Boosts Efficacy Of Cannabis Terpenes
Gb Sciences, Inc. 
Via Benzinga
Not So Fast With The Cannabis-COVID Treatment: Gb Sciences And Michigan State U Researchers Clarify
Following the promising study on cannabinoids and COVID-19 published by Oregon State University, Gb Sciences, Inc. 
Via Benzinga
The Week In Cannabis: Tilray Earnings And Reactions, Weed And Covid, Italy, Marijuana At The Airport And More
Below is a recap of the main news related to the cannabis industry and markets for the week of January 10, 2022. 
Via Benzinga
Gb Sciences Leaves Cannabis Cultivation With $8M Sale Of Las Vegas Facility, Enters BioPharma Industry
Gb Sciences, Inc. (OTCQB:GBLX) announced Tuesday that it ha... 
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.